Biotech Blog Archives: August 2002
next page ·
26 August 2002
Looking beyond Patent Expiry
Looking beyond Patent Expiry
The problem of patent protection loss and associated revenue loss will continue to trouble major companies, with estimated revenue losses of US$2.2 billion in 2004 from patent expiries on 18 drugs, increasing to an estimated US$5.3 billion in 2005.
continue reading... » 0 Comments
24 August 2002
Modified pigs are transplant ‘breakthrough’
Modified pigs are transplant ‘breakthrough’
A new breed of genetically engineered pigs with organs far less likely to be rejected by people has been created in the US.
The surfaces of the cloned pigs’ cells lack a key sugar, which triggers the violent hyperacute rejection response. This normally reduces transplanted organs to pulp within hours.
continue reading... » 0 Comments
23 August 2002
Send in the Clones
Send in the Clones
Will a relaxed attitude to regulation make Singapore the stem-cell-research capital of the world?
continue reading... » 0 Comments
21 August 2002
New breed of VCs banking on biotech
New breed of VCs banking on biotech
As the era of rock-star venture capitalists investing in Internet start-ups appears to be ending, another era is dawning — one of VCs flocking into biotech and health care.
continue reading... » 0 Comments
19 August 2002
Biology Seeks a Few Good Geeks
Biology Seeks a Few Good Geeks
The declaration is perhaps not as stirring as Uncle Sam calling patriotic men into the army in World War I, but Vicky Markstein is just as determined in her pursuit and convinced of its importance to the nation and the welfare of humanity.
continue reading... » 0 Comments
19 August 2002
Biotechs on edge as money evaporates
Biotechs on edge as money evaporates
Seattle’s biotech industry is working on some of the most complicated medical science in the world, but it relies on a simple mantra its executives know by heart: “Cash is king.”
